It is therefore possible that the increased cytotoxicity of entinostat observed in BRCA1 mutated cancer cells was caused by the impairment in the DNA damage response in addition to the homologous recombination deficiency caused by BRCA1 loss of function. Here, BRCA1 is linked to cancer.